Facebook Linkedin Mail Twitter

Home
Latest news
From the editor
- Commentary
Videos
Past Issues
Supplements
Events
Subscribe

Search

Facebook Linkedin Mail Twitter

Vascular Specialist

Home
Latest news
From the editor
- Commentary
Videos
Past Issues
Supplements
Events
Subscribe

News
Past Issues
Uncategorised

Vascular Specialist–February 2020

By

-

19th February 2020

2828

RELATED ARTICLES MORE FROM AUTHOR

One-year WAVE trial results show patency advantage for Wrapsody versus PTA

Study details radiation exposure learning curve among vascular trainees

Imperative Care expands Symphony thrombectomy portfolio with new FDA approval

LEAVE A REPLY Cancel reply

Please enter your comment!

Please enter your name here

You have entered an incorrect email address!

Please enter your email address here

Save my name, email, and website in this browser for the next time I comment.

Δ

Most read

Through the looking glass: Addressing bias in surgery

15th September 2020

When RCTs are essential for novel vascular access device regulation

17th December 2024

CPVI course: Learning the latest intricate skills and techniques to treat...

15th December 2024

From the editor

So you want to marry a surgeon?

4th March 2025

Marriage and other things I’m probably doing wrong

3rd January 2025

Track your wRVUs, because no one else does it better

4th December 2024

Commentary

Corner Stitch: Becoming a community-engaged vascular surgeon

9th March 2025

Senate scrutiny of HHS nominees poses key moment for vascular surgery...

7th March 2025

The torrid number of hospital mergers and integrations do not create...

3rd March 2025

Write to us
Editor: Bryan Kay [email protected]
Advertising: Nicole Schmitz [email protected]

United Kingdom:

BIBA Medical, Europe
526 Fulham Road, Fulham, London, SW6 5NR
TEL: +44 (0)20 7736 8788
Email: [email protected]

United States:

BIBA Medical, North America
155 North Wacker Drive, Suite 4250, Chicago, IL 60606
TEL: +1 949 723 9309
Email: [email protected]

Terms and Conditions | Privacy Policy

Facebook Linkedin Mail Twitter